Re: Thoughts on ZCC
in response to
by
posted on
Sep 05, 2021 12:27PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
NBB - I think it's more likely we see ZEL sold and money or shares or a combination there of distributed to current shareholders. ZCC would then be listed on a more recognizable exchange like the TSX or the NASDAQ for the royalty value. Since there are no royalties at this time or in the near future ZHCLF looks like what we will have for some time.
tada